PLK1 and colon carcinoma: It has been reported that pharmacological inhibition of PLK1 in colon carcinoma cells (HTC-116) induces p21 upregulation, leading to cell cycle arrest and, in turn, apoptosis or senescence depending on cellular context [47,48].